Split tolerance in a novel transgenic model of autoimmune myasthenia gravis.
Because it is one of the few autoimmune disorders in which the target autoantigen has been definitively identified, myasthenia gravis (MG) provides a unique opportunity for testing basic concepts of immune tolerance. In most MG patients, Abs against the acetylcholine receptors (AChR) at the neuromuscular junction can be readily identified and have been directly shown to cause muscle weakness. T cells have also been implicated and appear to play a role in regulating the pathogenic B cells. A murine MG model, generated by immunizing mice with heterologous AChR from the electric fish Torpedo californica, has been used extensively. In these animals, Abs cross-react with murine AChR; however, the T cells do not. Thus, to study tolerance to AChR, a transgenic mouse model was generated in which the immunodominant Torpedo AChR (T-AChR) alpha subunit is expressed in appropriate tissues. Upon immunization, these mice showed greatly reduced T cell responses to T-AChR and the immunodominant alpha-chain peptide. Limiting dilution assays suggest the likely mechanism of tolerance is deletion or anergy. Despite this tolerance, immunization with intact T-AChR induced anti-AChR Abs, including Abs against the alpha subunit, and the incidence of MG-like symptoms was similar to that of wild-type animals. Furthermore, evidence suggests that this B cell response to the alpha-chain receives help from T cells directed against the other AChR polypeptides (beta, gamma, or delta). This model offers a novel opportunity to elucidate mechanisms of tolerance regulation to muscle AChR and to clarify the role of T cells in MG.
Stacy
Sue
S
Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio 78229, USA.
Gelb
Bruce E
BE
Koop
Barbara A
BA
Windle
Jolene J
JJ
Wall
Katherine A
KA
Krolick
Keith A
KA
Infante
Anthony J
AJ
Kraig
Ellen
E
D000818:Animals; D001324:Autoantigens; D001402:B-Lymphocytes / Q000276:immunology; D001483:Base Sequence; D018076:DNA, Complementary / Q000235:genetics; D004195:Disease Models, Animal; D006801:Humans; D007108:Immune Tolerance; D007114:Immunization; D016056:Immunodominant Epitopes / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D020720:Myasthenia Gravis, Autoimmune, Experimental / Q000276:immunology*; D021122:Protein Subunits; D011950:Receptors, Cholinergic / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014101:Torpedo
D001324:Autoantigens; D018076:DNA, Complementary; D016056:Immunodominant Epitopes; D021122:Protein Subunits; D011950:Receptors, Cholinergic